Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When is tenofovir alafenamide patent expiring?Dabrafenib and trametinib price?What's the recommended schedule for lurbinectedin side effect checks?What's the impact of mixing lipitor bp meds negatively?Sun pharma bortezomib?
See the DrugPatentWatch profile for ruxolitinib
The exact filing date of Apotex’s ruxolitinib ANDA is not provided in the information available to me here, so I can’t state a precise day/month/year without risking an error. To get the exact filing date, the most reliable places to check are the FDA’s ANDA database (ANDA number + submission details) or the Orange Book/FDAS/related FDA records that list the ANDA submission and related milestones.
Search in these FDA-facing sources using Apotex’s ANDA identifier for ruxolitinib: - The FDA ANDA submission details in the ANDA database (shows the relevant filing/submission date) - The FDA Orange Book entry for ruxolitinib (usually linked to the applicant/ANDA; the Orange Book itself sometimes doesn’t show the exact filing day, but it helps you find the correct ANDA number to look up)
If you tell me either: - Apotex’s ruxolitinib ANDA number, or - the specific product strength/form (e.g., tablet strength) and market (US), I can help you zero in on the exact submission record you need to confirm the filing date from the FDA listing. Sources: None (no provided source material includes the ANDA filing date).
Other Questions About Ruxolitinib :